Seven Percent of Outpatients Experience One or More Adverse Event
By Elana Gotkine HealthDay Reporter
MONDAY, May 6, 2024 -- Among outpatients, 7.0 percent have at least one adverse event (AE), with adverse drug events being the most common, according to a study published online May 7 in the Annals of Internal Medicine.
Noting that knowledge of outpatient AEs remains limited, David M. Levine, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues describe the frequency and types of harm that occurred at 11 outpatient sites during one year. Data were reviewed for 3,103 patients who received outpatient care. Possible AEs were identified by nurse reviewers and adjudicated by physicians.
The researchers found that 7.0 percent of patients had at least one AE (8.6 events per 100 patients per year). The most common AEs were adverse drug events, health care-associated infections, and surgical or procedural events (63.8, 14.8, and 14.2 percent, respectively). AEs were never fatal; 17.4 and 2.1 percent were serious and life-threatening, respectively. Of the AEs, 23.2 percent were preventable. Having at least one AE occurred less often at ages 18 to 44 years versus ages 65 to 84 years (standardized risk difference, −0.05) and occurred more often with Black versus Asian race (standardized risk difference, 0.09). Overall, 1.8 to 23.6 percent of patients had at least one AE across study sites; there was considerable variation observed in the clinical category of AEs.
"We believe these data serve as an urgent call for patient safety research and innovation in the outpatient setting," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.